AI Verdict
ESP has stronger fundamentals based on our AI analysis.
ESPR vs ESP Fundamental Comparison
| Metric | ESPR | ESP |
|---|---|---|
| Revenue | $403.1M | $21.2M |
| Net Income | $-22.7M | $5.0M |
| Net Margin | -5.6% | 23.4% |
| ROE | N/A | 9.4% |
| ROA | -4.9% | 5.8% |
| Current Ratio | 1.54x | 2.53x |
| Debt/Equity | N/A | 0.00x |
| EPS | $-0.11 | $1.75 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
ESPR vs ESP: Frequently Asked Questions
Is ESPR or ESP a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), ESP has stronger fundamentals. ESPR is rated SELL (78% confidence) while ESP is rated BUY (72% confidence). This is not investment advice.
How does ESPR compare to ESP fundamentally?
Esperion Therapeutics, Inc. has ROE of N/A vs ESPEY MFG & ELECTRONICS CORP's 9.4%. Net margins are -5.6% vs 23.4% respectively.
Which stock pays higher dividends, ESPR or ESP?
ESPR has a dividend yield of N/A or no dividend while ESP has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in ESPR or ESP for long term?
For long-term investing, consider that ESPR has SELL rating with 78% confidence, while ESP has BUY rating with 72% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about ESPR vs ESP?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For ESPR vs ESP, the AI consensus favors ESP based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.